Clinical Trials Browser

Phase 3 × capivasertib × 30 days × Clear all

NCT06764186 2026-04-08

CAPItana

Phase 3 Active not recruiting

Breast Neoplasms

NCT06982521 2026-04-02

ReDiscover-2

Phase 3 Recruiting

Breast Neoplasms

NCT04493853 2026-04-01

CAPItello-281

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT06635447 2026-03-27

CAPItrue

Phase 3 Active not recruiting

Breast Neoplasms, Disease Progression